异动解读|Kodiak Sciences Inc.盘中上涨5.3%,董事大额增持后市场继续消化利好

行情直击
Oct 27

10月27日,Kodiak Sciences Inc.盘中上涨5.3%,报94.385美元/股,成交额1466.14万美元。

消息面上,较新的公开信息显示,公司董事兼重要股东Felix Baker此前通过关联机构大举买入公司股份,被市场视为积极信号。

具体来看,Felix Baker于9月末斥资约1.57亿美元、以每股80.85美元增持,相关机构对该笔交易评价为其迄今最大一笔买入;在此之前,公司于9月公布两款眼科候选药物在三期试验中达到主要终点,显著提振了市场对其后续申报与产品前景的预期。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10